To validate these findings, we further confirmed that high expression levels of CCL2/CCR2 and CXCL8/CXCR2 were associated with poor prognosis in clinical HCC specimens and correlated with hepatocarcinogenesis progression in the primary rat HCC model. Here, CXCL8 is linked to hepatocellular carcinoma.